These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 8134661

  • 21. Enhanced protection against Q fever in BALB/c mice elicited by immunization of chloroform-methanol residue of Coxiella burnetii via intratracheal inoculation.
    Feng J, Hu X, Fu M, Dai L, Yu Y, Luo W, Zhao Z, Lu Z, Du Z, Zhou D, Wen B, Jiao J, Xiong X.
    Vaccine; 2019 Sep 24; 37(41):6076-6084. PubMed ID: 31477436
    [Abstract] [Full Text] [Related]

  • 22. Search for correlates of resistance to virulent challenge in mice immunized with Coxiella burnetii.
    Kazár J, El-Najdawi E, Brezina R, Schramek S.
    Acta Virol; 1977 Sep 24; 21(5):422-30. PubMed ID: 22238
    [Abstract] [Full Text] [Related]

  • 23. Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990.
    Ackland JR, Worswick DA, Marmion BP.
    Med J Aust; 1994 Jun 06; 160(11):704-8. PubMed ID: 8202006
    [Abstract] [Full Text] [Related]

  • 24. Cell-mediated immune response to Coxiella burnetii antigens in Q fever convalescents and vaccinees.
    Gajdosová E, Brezina R.
    Acta Virol; 1989 Sep 06; 33(5):474-81. PubMed ID: 2576587
    [Abstract] [Full Text] [Related]

  • 25. Antibody response in man following a small intradermal inoculation with Coxiella burnetii phase I vaccine.
    Peacock MG, Fiset P, Ormsbee RA, Wisseman CL.
    Acta Virol; 1979 Jan 06; 23(1):73-81. PubMed ID: 35962
    [Abstract] [Full Text] [Related]

  • 26. Balb/c mouse model and real-time quantitative polymerase chain reaction for evaluation of the immunoprotectivity against Q fever.
    Zhang J, Wen B, Chen M, Zhang J, Niu D.
    Ann N Y Acad Sci; 2005 Dec 06; 1063():171-5. PubMed ID: 16481510
    [Abstract] [Full Text] [Related]

  • 27. Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii.
    Waag DM, England MJ, Bolt CR, Williams JC.
    Clin Vaccine Immunol; 2008 Oct 06; 15(10):1505-12. PubMed ID: 18701647
    [Abstract] [Full Text] [Related]

  • 28. Chloroform-Methanol Residue of Coxiella burnetii Markedly Potentiated the Specific Immunoprotection Elicited by a Recombinant Protein Fragment rOmpB-4 Derived from Outer Membrane Protein B of Rickettsia rickettsii in C3H/HeN Mice.
    Gong W, Wang P, Xiong X, Jiao J, Yang X, Wen B.
    PLoS One; 2015 Oct 06; 10(4):e0124664. PubMed ID: 25909586
    [Abstract] [Full Text] [Related]

  • 29. Autoimmune component in individuals during immune response to inactivated combined vaccine against Q fever.
    Krutitskaya L, Tokarevich N, Zhebrun A, Kartseva N, Tarasevich I, Yablonskaya V, Fatalieva S, Misnikov OP, Vasilenko AZ.
    Acta Virol; 1996 Sep 06; 40(4):173-7. PubMed ID: 9014006
    [Abstract] [Full Text] [Related]

  • 30. Protective immunity against Q fever induced with a recombinant P1 antigen fused with HspB of Coxiella burnetii.
    Li Q, Niu D, Wen B, Chen M, Qiu L, Zhang J.
    Ann N Y Acad Sci; 2005 Dec 06; 1063():130-42. PubMed ID: 16481504
    [Abstract] [Full Text] [Related]

  • 31. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M, Habermehl P, Faber J, Bock HL, Sänger R, Bogaerts H, Clemens R, Schuind A, du Prel JB, Schmitt HJ.
    Vaccine; 2006 Jul 07; 24(27-28):5627-36. PubMed ID: 16740348
    [Abstract] [Full Text] [Related]

  • 32. Long-term persistence of Coxiella burnetii after acute primary Q fever.
    Marmion BP, Storm PA, Ayres JG, Semendric L, Mathews L, Winslow W, Turra M, Harris RJ.
    QJM; 2005 Jan 07; 98(1):7-20. PubMed ID: 15625349
    [Abstract] [Full Text] [Related]

  • 33. Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10 ScN mice.
    Williams JC, Damrow TA, Waag DM, Amano K.
    Infect Immun; 1986 Mar 07; 51(3):851-8. PubMed ID: 3949384
    [Abstract] [Full Text] [Related]

  • 34. Assessment of vaccination by a phase I Coxiella burnetii-inactivated vaccine in goat herds in clinical Q fever situation.
    de Cremoux R, Rousset E, Touratier A, Audusseau G, Nicollet P, Ribaud D, David V, Le Pape M.
    FEMS Immunol Med Microbiol; 2012 Feb 07; 64(1):104-6. PubMed ID: 22066485
    [Abstract] [Full Text] [Related]

  • 35. Prevention of Coxiella burnetii shedding in infected dairy herds using a phase I C. burnetii inactivated vaccine.
    Guatteo R, Seegers H, Joly A, Beaudeau F.
    Vaccine; 2008 Aug 12; 26(34):4320-8. PubMed ID: 18586060
    [Abstract] [Full Text] [Related]

  • 36. Immunity in Q fever.
    Kazár J.
    Acta Virol; 1988 Jul 12; 32(4):358-68. PubMed ID: 2903642
    [Abstract] [Full Text] [Related]

  • 37. Failure of Q fever phase I corpuscular vaccine to influence the persistence and reactivation of Coxiella burnetii infection in mouse and guinea pig tissues.
    Kazár J, Kovácová E.
    Acta Virol; 1983 Sep 12; 27(5):418-28. PubMed ID: 6139946
    [Abstract] [Full Text] [Related]

  • 38. Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma.
    Wang F, Bade E, Kuniyoshi C, Spears L, Jeffery G, Marty V, Groshen S, Weber J.
    Clin Cancer Res; 1999 Oct 12; 5(10):2756-65. PubMed ID: 10537339
    [Abstract] [Full Text] [Related]

  • 39. Current status and potential application of ISCOMs in veterinary medicine.
    Morein B, Hu KF, Abusugra I.
    Adv Drug Deliv Rev; 2004 Jun 23; 56(10):1367-82. PubMed ID: 15191787
    [Abstract] [Full Text] [Related]

  • 40. Suitability of various Coxiella burnetii antigen preparations for detection of serum antibodies by various tests.
    Kovácová E, Kazár J, Spanĕlová D.
    Acta Virol; 1998 Dec 23; 42(6):365-8. PubMed ID: 10358741
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.